No fatal dose of melatonin alone has ever been established in humans. There is no published LD50 (the dose expected to kill half of those who take it), and the handful of massive overdose cases in the medical literature have resulted in survival with relatively mild symptoms. That does not mean melatonin is completely harmless in any quantity, but the toxicological picture is unusual for a substance sold on virtually every pharmacy shelf: people have ingested hundreds of milligrams at once and walked out of the hospital the same day. The real risks of melatonin sit in less obvious places than the dose itself.
What Overdose Case Reports Show
Published case reports of deliberate melatonin overdose paint a surprisingly benign picture. A 42-year-old woman who intentionally swallowed 120 mg of melatonin (sixty 2-mg tablets) in a suicide attempt arrived at the emergency department about an hour later. Doctors performed gastric lavage and administered activated charcoal. Her only symptoms were drowsiness and mild hypothermia, with a body temperature of 34°C. After twelve hours of monitoring, she was discharged and referred for psychiatric care.1PubMed Central. Attempted suicide by Melatonin overdose: Case report and literature review
An even more dramatic case involved a 16-year-old boy who deliberately ingested 900 mg of melatonin (180 tablets) along with 5 mg of alprazolam, a benzodiazepine. He arrived at the emergency department extremely drowsy and minimally responsive, scoring 8 out of 15 on the Glasgow Coma Scale. Yet his vital signs remained stable throughout, and doctors found no signs of kidney or liver damage. The authors concluded that even at a dose as high as 900 mg, melatonin did not produce severe adverse effects beyond heavy sedation.2PubMed Central. Case report on melatonin overdose: Cause and concern
These cases are instructive because they sit at the extreme end of what anyone would plausibly ingest, and the outcomes were still manageable with standard emergency care. The 900-mg case is especially striking because the patient also took a sedative on top of it, which would be expected to compound any respiratory or neurological depression. His body handled both.
The One Known Death Linked to Melatonin
There is, however, one published forensic case in which melatonin was listed as a contributing cause of death. A decedent was found with extremely elevated blood concentrations of both diphenhydramine (the active ingredient in Benadryl and many over-the-counter sleep aids) and melatonin. The melatonin concentrations in the blood were 3.9 mg/L and 4.4 mg/L in different samples, and gastric contents showed a melatonin concentration of 130 mg/L. Because both substances were present at high levels, the death was certified as suicide by acute combined diphenhydramine and melatonin toxicity.3PubMed Central. Case Report of Lethal Concentrations of the Over-the-Counter Sleep Aids Diphenhydramine and Melatonin
This case is important but needs careful interpretation. Diphenhydramine on its own can be lethal in overdose. It causes seizures, cardiac arrhythmias, and respiratory failure at high doses. The forensic examiners classified the death as a combined toxicity, meaning they judged that melatonin contributed, but it is impossible to know from a single case whether melatonin alone at those blood levels would have been fatal. No published case has documented a death from melatonin without another drug present. That absence of evidence is not proof of absolute safety, but it tells you something about the substance’s toxicological profile.
Why Melatonin Is So Difficult to Fatally Overdose On
The body clears melatonin fast. After you swallow it, the hormone undergoes rapid first-pass metabolism in the liver, where more than 80 percent is converted into an inactive metabolite called 6-sulfatoxymelatonin and excreted in the urine.4PubMed. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder The liver enzyme primarily responsible for this breakdown is CYP1A2, which is active and abundant in most people.5PubMed. Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices The half-life of oral melatonin is typically in the range of 20 to 50 minutes, meaning blood levels drop by half in under an hour for most people.
This rapid clearance is the main reason enormous oral doses produce such unexpectedly mild effects. Your liver metabolizes melatonin so efficiently that a large chunk of any oral dose never reaches high circulating concentrations for long. Even if you swallow many times the normal dose, the body’s disposal system is working hard the whole time, keeping peak blood levels lower and shorter-lived than you might expect for that amount of substance.
A broad safety review looking at both animal and human data concluded that short-term melatonin use is safe even in what the authors called “extreme doses,” with only mild adverse effects like dizziness, headache, nausea, and sleepiness reported. No studies the reviewers examined indicated that melatonin should produce serious adverse effects.6PubMed. The Safety of Melatonin in Humans Similarly, a systematic review and meta-analysis of high-dose melatonin trials, covering nearly 4,000 participants, found that melatonin did not cause a detectable increase in serious adverse events. It did increase milder problems like drowsiness, headache, and dizziness, but the authors noted that the overall safety profile looked good based on available evidence.7PubMed. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
Where the Real Danger Lies: Drug Interactions
If melatonin itself has an extraordinarily wide safety margin, the risks multiply when it interacts with other substances. Because CYP1A2 is the main enzyme responsible for breaking melatonin down, anything that inhibits CYP1A2 can slow melatonin clearance and raise blood levels higher than expected. Drugs that interact with CYP1A2 are the most likely candidates for clinically meaningful interactions.4PubMed. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder
One well-documented example involved a 19-year-old man who was already taking citalopram (an SSRI antidepressant), nortriptyline (a tricyclic antidepressant), and oxycodone (an opioid). When melatonin was added to that regimen, he experienced severe sedation. Analysis suggested the interaction was primarily between melatonin and citalopram, though the melatonin product also showed inhibition of multiple liver enzymes in lab testing.8Journal of Pharmacy & Pharmaceutical Sciences. Melatonin Interaction Resulting in Severe Sedation A person taking opioids, sedatives, or certain antidepressants is already in a vulnerable state where additional sedation can depress breathing or impair consciousness in dangerous ways. Melatonin’s sedative effect, ordinarily mild, can tip the balance.
Laboratory screening of potential drug interactions found that the potent CYP1A2 inhibitor 5-methoxypsoralen did impair melatonin metabolism at clinically relevant concentrations, while common drugs like diazepam, tamoxifen, and acetaminophen did not meaningfully block melatonin’s breakdown.9PubMed. Potential drug interactions with melatonin Fluvoxamine, another SSRI, is one of the strongest CYP1A2 inhibitors in clinical use and is well known to dramatically increase melatonin blood levels. If you are taking any medication metabolized by the same liver pathway, the effective dose of melatonin you experience can be far higher than the number on the bottle.
Children Face Different Risks
The pediatric picture is more concerning. Between 2012 and 2021, U.S. poison control centers tracked a surge in pediatric melatonin ingestions. Hospitalizations and more serious outcomes increased over that period, driven primarily by unintentional ingestions among children five and younger. Five children required mechanical ventilation, and two died.10PubMed Central. Pediatric Melatonin Ingestions – United States, 2012-2021 The details of those deaths have not been fully published, and it remains unclear whether melatonin alone was responsible or whether other substances or underlying conditions played a role. Still, the fact that two pediatric deaths occurred in the dataset stands out against the adult record of near-zero fatalities.
More recent emergency department data from 2019 to 2022 showed over 4,000 ED visits for unsupervised pediatric melatonin ingestion across 26 participating hospitals. The vast majority, about 84 percent, involved children under five, and nearly half involved two- and three-year-olds specifically. Most children were treated and released the same day, but roughly 9 percent were hospitalized and about half a percent required critical care.11PubMed Central. Notes from the Field: Emergency Department Visits for Unsupervised Pediatric Melatonin Ingestion – United States, 2019-2022
Children’s smaller body size means a given milligram dose hits them harder. Their liver enzyme systems are also not fully mature, which can slow drug clearance. Melatonin gummies marketed to kids often look and taste like candy, and because there is no childproof cap requirement for supplements in the U.S., unsupervised access is common. The practical risk for children is less about a theoretical lethal dose and more about the sheer availability and palatability of the product in homes where it’s treated as harmless.
What Is Actually in the Bottle
Part of the hazard picture with melatonin has nothing to do with melatonin itself and everything to do with what supplements actually contain. A Canadian study that tested a range of commercially available melatonin products found that the actual melatonin content ranged from 83 percent less to 478 percent more than what the label stated. Even different lots of the same product from the same manufacturer varied by as much as 465 percent. To make matters worse, serotonin, a controlled substance in pharmaceutical form, was detected in eight of the tested supplements.12PubMed Central. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content
This variability matters for safety in a way that goes beyond melatonin alone. If your 3-mg tablet actually contains 14 mg, you are getting a very different pharmacological experience than you bargained for. More concerning is the serotonin contamination. Serotonin interacts with many psychiatric medications and can, in rare cases, contribute to serotonin syndrome when combined with SSRIs or other serotonergic drugs. A person who thought they were only taking melatonin could unknowingly introduce a second substance that interacts with their medication. In countries where melatonin is sold as an unregulated supplement rather than a prescription drug, this kind of quality control failure is difficult for consumers to avoid.
Cardiovascular Effects at High Doses
Melatonin’s effects on the heart and blood vessels are real but complicated, and they illustrate why asking about a “fatal dose” may be the wrong framing. In healthy men, a single dose of melatonin lowered blood pressure and reduced circulating levels of norepinephrine and dopamine within an hour, essentially shifting the nervous system toward a more relaxed state.13PubMed. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men A three-week trial in men with untreated high blood pressure found that nightly melatonin reduced blood pressure during sleep by about 6 mmHg systolic and 4 mmHg diastolic.14PubMed. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
But the picture flips in certain contexts. In patients with high blood pressure already controlled by the calcium-channel blocker nifedipine, evening melatonin actually raised blood pressure and heart rate over a 24-hour period, with systolic pressure increasing by about 6.5 mmHg and diastolic by about 5 mmHg.15PubMed Central. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study The interaction between melatonin and specific blood pressure medications may produce opposite effects from what you would see in someone not on those drugs. For someone with cardiovascular disease who is already on medication, adding high-dose melatonin is not a neutral act even if the dose itself is not anywhere close to “fatal.”
People Who Clear Melatonin Slowly
The body’s ability to quickly metabolize melatonin is the main reason overdoses are so survivable. But not everyone clears it efficiently. People with chronic kidney failure show significantly elevated baseline melatonin levels compared to healthy individuals, because the kidney is a major route for excreting melatonin’s breakdown products. Studies of patients on dialysis and peritoneal dialysis both found elevated daytime plasma melatonin, and successful kidney transplantation brought those levels back down markedly.16Nephron. Melatonin in Chronic Renal Failure If your kidneys are failing, supplemental melatonin can accumulate to higher levels than it would in someone with normal kidney function, and the effects, including excessive sedation and cardiovascular shifts, would be amplified.
Liver disease presents a similar concern, since the liver handles the initial breakdown step. Anyone with significantly impaired liver function, whether from cirrhosis, hepatitis, or other conditions, will metabolize melatonin more slowly and sustain higher blood levels from the same dose. This population has not been well studied with melatonin specifically, which itself is a warning sign. The reassuring safety data we have comes overwhelmingly from people with functioning livers and kidneys.
Hormonal Effects That Have Nothing to Do with Sleep
At high or chronic doses, melatonin does more than make you sleepy. It acts on the hormonal system in ways that researchers are still mapping. Animal research has shown that melatonin can suppress the hypothalamic-pituitary-gonadal axis, reducing circulating levels of reproductive hormones like FSH, LH, and estradiol.17PubMed. Therapeutic effects of melatonin in female mice with central precocious puberty by regulating the hypothalamic Kiss-1/Kiss1R system In that particular study, the effect was actually beneficial: melatonin was being tested as a treatment for precocious puberty in mice. But the same mechanism could be concerning if high-dose melatonin is taken by children or adolescents going through normal pubertal development. The long-term hormonal consequences of sustained high melatonin exposure in growing humans have not been established, largely because long-term safety data for children is still thin.
Adults are not immune to these hormonal effects either. Melatonin interacts with thyroid function, insulin sensitivity, and cortisol rhythms. None of these interactions are acutely dangerous at typical supplement doses, but they represent another reason why “not fatal” is a very different statement from “completely safe.” A substance that disrupts your reproductive hormones or insulin regulation over months of use can cause meaningful health problems that never show up in an emergency department overdose report.
Why the United States Treats Melatonin Differently
In most of Europe, Australia, and parts of Asia, melatonin is available only by prescription. In the United States, it is classified as a dietary supplement under the 1994 Dietary Supplement Health and Education Act, meaning it faces no premarket safety testing, no dosage limits, and minimal manufacturing oversight. This regulatory gap explains the label accuracy problems discussed earlier and helps explain why pediatric accidental ingestions have surged. The U.S. market has seen a proliferation of high-dose melatonin products, including gummies marketed specifically to children, with doses climbing from the 1-3 mg range that was common a decade ago to 5, 10, and even 20 mg per serving.
The absence of a known fatal dose has fed a cultural perception that melatonin is basically a vitamin. People who would never give their child an unregulated dose of a prescription sedative think nothing of handing them a melatonin gummy that may contain several times the labeled dose and possibly traces of serotonin. The regulatory classification has shaped consumer behavior in ways that outpace the safety data. Researchers have pointed out that the limited adverse-event reporting in high-dose studies means our confidence in melatonin’s safety profile is based on a surprisingly small foundation, with wide confidence intervals around the reassuring numbers.7PubMed. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis The evidence says melatonin looks safe. It also says we have not looked as hard as you might assume.